Profil
Eric Rojas is currently the Vice President of Investor Relations at Stoke Therapeutics, Inc. He previously worked as a Senior Director of Investor Relations at Shire Plc.
Aktive Positionen von Eric Rojas
| Unternehmen | Position | Beginn |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Eric Rojas
| Unternehmen | Position | Ende |
|---|---|---|
| SHIRE | Investor Relations Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| STOKE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
